Views provided by UsageCounts
The data support the findings of the study "The Unfolded Protein Response in Amyotrophic Later Sclerosis: Results of a Phase 2 Trial". They include demographic and clinical data at baseline, and changes measured by the primary and secondary outcomes at 6 months
grant no. FGCR 01/2013 - Ari-SLA - Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica
Guanabenz, Amyotrophic Lateral Sclerosis, Unfolded Protein Response, phase 2 trial
Guanabenz, Amyotrophic Lateral Sclerosis, Unfolded Protein Response, phase 2 trial
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 21 |

Views provided by UsageCounts